Processa Pharmaceuticals
PCSA
PCSA
22 hedge funds and large institutions have $853K invested in Processa Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $1.28M → $853K (-$424K)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$389K | |
| 2 | +$31.3K | |
| 3 | +$27K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.2K |
| 5 |
Renaissance Technologies
New York
|
+$8.77K |
Top Sellers
| 1 | -$334K | |
| 2 | -$78K | |
| 3 | -$17.4K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.07K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |